Renalytix Total Current Liabilities vs Net Tangible Assets Analysis

RNLX Stock

USD 0.16 0.01 6.67%

Renalytix financial indicator trend analysis is much more than just breaking down Renalytix AI prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Renalytix AI is a good investment. Please check the relationship between Renalytix Total Current Liabilities and its Net Tangible Assets accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Renalytix AI. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Total Current Liabilities vs Net Tangible Assets

Total Current Liabilities vs Net Tangible Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Renalytix AI Total Current Liabilities account and Net Tangible Assets. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Renalytix's Total Current Liabilities and Net Tangible Assets is 0.42. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Net Tangible Assets in the same time period over historical financial statements of Renalytix AI, assuming nothing else is changed. The correlation between historical values of Renalytix's Total Current Liabilities and Net Tangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Renalytix AI are associated (or correlated) with its Net Tangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Tangible Assets has no effect on the direction of Total Current Liabilities i.e., Renalytix's Total Current Liabilities and Net Tangible Assets go up and down completely randomly.

Correlation Coefficient

0.42

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Total Current Liabilities

Total Current Liabilities is an item on Renalytix balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Renalytix AI are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Net Tangible Assets

The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.

Most indicators from Renalytix's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Renalytix AI current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Renalytix AI. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

At this time, Renalytix's Tax Provision is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 21.7 M in 2024, whereas Selling General Administrative is likely to drop slightly above 18.7 M in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	58.3M	43.1M	29.0M	33.2M
Cost Of Revenue	2.1M	2.7M	2.1M	1.4M

Total Operating Expenses Cost Of Revenue

Renalytix fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Net Working Capital	Short Term Debt	Common Stock	Other Current Liab	Property Plant And Equipment Net	Accounts Payable	Non Currrent Assets Other	Short Term Investments
Total Assets		0.34	0.56	0.96	0.94	-0.96	0.04	0.98	0.98	0.77	0.7	0.15	0.4	0.59	0.51	0.88	0.18	0.98	0.91	0.3	0.43	0.64	0.89	0.53	-0.06	0.83
Short Long Term Debt Total	0.34		0.93	0.09	0.17	-0.14	-0.7	0.38	0.35	0.69	0.67	0.68	0.99	0.85	0.96	0.49	0.92	0.37	0.37	0.99	0.75	0.67	0.5	0.77	0.73	0.05
Total Current Liabilities	0.56	0.93		0.32	0.42	-0.37	-0.68	0.58	0.56	0.86	0.81	0.72	0.92	0.95	0.99	0.71	0.87	0.58	0.59	0.93	0.86	0.75	0.58	0.87	0.59	0.33
Total Stockholder Equity	0.96	0.09	0.32		0.95	-0.98	0.27	0.93	0.94	0.61	0.54	-0.04	0.15	0.37	0.27	0.78	-0.08	0.94	0.85	0.04	0.23	0.5	0.82	0.32	-0.28	0.85
Net Tangible Assets	0.94	0.17	0.42	0.95		-0.97	0.03	0.95	0.96	0.76	0.6	0.19	0.2	0.52	0.35	0.87	0.1	0.96	0.96	0.15	0.38	0.44	0.81	0.41	-0.09	0.94
Net Debt	-0.96	-0.14	-0.37	-0.98	-0.97		-0.2	-0.97	-0.97	-0.7	-0.5	-0.11	-0.17	-0.44	-0.31	-0.77	0.02	-0.97	-0.88	-0.09	-0.24	-0.55	-0.85	-0.3	0.26	-0.92
Retained Earnings	0.04	-0.7	-0.68	0.27	0.03	-0.2		0.0	0.01	-0.53	-0.53	-0.74	-0.61	-0.73	-0.67	-0.37	-0.9	0.0	-0.23	-0.76	-0.8	-0.14	0.05	-0.59	-0.83	0.02
Cash	0.98	0.38	0.58	0.93	0.95	-0.97	0.0		1.0	0.84	0.63	0.28	0.41	0.63	0.54	0.85	0.23	1.0	0.93	0.33	0.42	0.68	0.92	0.48	-0.05	0.88
Cash And Short Term Investments	0.98	0.35	0.56	0.94	0.96	-0.97	0.01	1.0		0.83	0.62	0.27	0.38	0.62	0.51	0.84	0.2	1.0	0.93	0.31	0.4	0.66	0.91	0.46	-0.07	0.9
Net Receivables	0.77	0.69	0.86	0.61	0.76	-0.7	-0.53	0.84	0.83		0.75	0.71	0.66	0.93	0.81	0.85	0.66	0.84	0.87	0.69	0.75	0.68	0.75	0.68	0.37	0.75
Common Stock Total Equity	0.7	0.67	0.81	0.54	0.6	-0.5	-0.53	0.63	0.62	0.75		0.38	0.7	0.83	0.78	0.9	0.65	0.65	0.71	0.68	0.9	0.48	0.55	0.86	0.5	0.42
Common Stock Shares Outstanding	0.15	0.68	0.72	-0.04	0.19	-0.11	-0.74	0.28	0.27	0.71	0.38		0.57	0.79	0.69	0.33	0.74	0.27	0.34	0.74	0.69	0.41	0.26	0.5	0.53	0.29
Non Current Liabilities Total	0.4	0.99	0.92	0.15	0.2	-0.17	-0.61	0.41	0.38	0.66	0.7	0.57		0.81	0.96	0.52	0.88	0.41	0.38	0.96	0.72	0.7	0.55	0.82	0.7	0.04
Other Stockholder Equity	0.59	0.85	0.95	0.37	0.52	-0.44	-0.73	0.63	0.62	0.93	0.83	0.79	0.81		0.92	0.77	0.84	0.63	0.68	0.87	0.91	0.65	0.57	0.77	0.57	0.48
Total Liab	0.51	0.96	0.99	0.27	0.35	-0.31	-0.67	0.54	0.51	0.81	0.78	0.69	0.96	0.92		0.65	0.89	0.54	0.53	0.96	0.82	0.75	0.58	0.87	0.64	0.24
Net Invested Capital	0.88	0.49	0.71	0.78	0.87	-0.77	-0.37	0.85	0.84	0.85	0.9	0.33	0.52	0.77	0.65		0.49	0.86	0.94	0.48	0.74	0.48	0.71	0.74	0.3	0.74
Short Long Term Debt	0.18	0.92	0.87	-0.08	0.1	0.02	-0.9	0.23	0.2	0.66	0.65	0.74	0.88	0.84	0.89	0.49		0.22	0.35	0.95	0.81	0.43	0.29	0.77	0.88	0.02
Total Current Assets	0.98	0.37	0.58	0.94	0.96	-0.97	0.0	1.0	1.0	0.84	0.65	0.27	0.41	0.63	0.54	0.86	0.22		0.93	0.33	0.42	0.67	0.92	0.5	-0.04	0.88
Net Working Capital	0.91	0.37	0.59	0.85	0.96	-0.88	-0.23	0.93	0.93	0.87	0.71	0.34	0.38	0.68	0.53	0.94	0.35	0.93		0.35	0.55	0.47	0.8	0.57	0.16	0.89
Short Term Debt	0.3	0.99	0.93	0.04	0.15	-0.09	-0.76	0.33	0.31	0.69	0.68	0.74	0.96	0.87	0.96	0.48	0.95	0.33	0.35		0.81	0.61	0.44	0.77	0.77	0.04
Common Stock	0.43	0.75	0.86	0.23	0.38	-0.24	-0.8	0.42	0.4	0.75	0.9	0.69	0.72	0.91	0.82	0.74	0.81	0.42	0.55	0.81		0.38	0.32	0.83	0.67	0.29
Other Current Liab	0.64	0.67	0.75	0.5	0.44	-0.55	-0.14	0.68	0.66	0.68	0.48	0.41	0.7	0.65	0.75	0.48	0.43	0.67	0.47	0.61	0.38		0.68	0.52	0.0	0.4
Property Plant And Equipment Net	0.89	0.5	0.58	0.82	0.81	-0.85	0.05	0.92	0.91	0.75	0.55	0.26	0.55	0.57	0.58	0.71	0.29	0.92	0.8	0.44	0.32	0.68		0.49	0.1	0.68
Accounts Payable	0.53	0.77	0.87	0.32	0.41	-0.3	-0.59	0.48	0.46	0.68	0.86	0.5	0.82	0.77	0.87	0.74	0.77	0.5	0.57	0.77	0.83	0.52	0.49		0.62	0.23
Non Currrent Assets Other	-0.06	0.73	0.59	-0.28	-0.09	0.26	-0.83	-0.05	-0.07	0.37	0.5	0.53	0.7	0.57	0.64	0.3	0.88	-0.04	0.16	0.77	0.67	0.0	0.1	0.62		-0.22
Short Term Investments	0.83	0.05	0.33	0.85	0.94	-0.92	0.02	0.88	0.9	0.75	0.42	0.29	0.04	0.48	0.24	0.74	0.02	0.88	0.89	0.04	0.29	0.4	0.68	0.23	-0.22

Click cells to compare fundamentals

Renalytix Account Relationship Matchups

Renalytix fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	41.3M	102.6M	63.3M	42.1M	8.0M	7.6M
Total Current Liabilities	3.4M	7.3M	12.2M	16.1M	11.5M	8.1M
Total Stockholder Equity	36.0M	95.1M	43.2M	18.5M	(7.9M)	(7.5M)
Net Tangible Assets	18.8M	71.5M	30.6M	7.0M	8.0M	7.6M
Net Debt	(12.7M)	(64.8M)	(28.6M)	(12.5M)	3.9M	4.0M
Retained Earnings	34.9M	3.8M	(53.0M)	(99.2M)	(211.8M)	(201.2M)
Cash	13.3M	65.2M	41.3M	24.7M	4.7M	4.4M
Non Current Assets Total	22.4M	26.6M	15.8M	13.8M	1.9M	1.8M
Cash And Short Term Investments	14.3M	74.5M	44.1M	26.1M	4.7M	4.4M
Net Receivables	18K	1.2M	901K	776K	722K	573.3K
Common Stock Shares Outstanding	29.5M	71.5M	73.8M	82.2M	108.2M	69.2M
Liabilities And Stockholders Equity	41.3M	102.6M	63.3M	42.1M	8.0M	7.6M
Non Current Liabilities Total	2.0M	213K	7.9M	7.5M	4.3M	3.6M
Other Stockholder Equity	2.8M	150.4M	164.0M	186.5M	204.9M	116.8M
Total Liab	5.3M	7.5M	20.1M	23.7M	15.8M	11.5M
Net Invested Capital	36.2M	71.5M	42.9M	30.4M	35.0M	38.4M
Short Long Term Debt	121K	53K	4.7M	4.5M	5.1M	5.4M
Total Current Assets	18.9M	76.0M	47.4M	28.3M	6.1M	5.8M
Net Working Capital	15.5M	59.7M	33.0M	12.2M	14.0M	23.7M
Common Stock	192K	233K	241K	299K	478K	265.2K
Other Current Liab	271K	4.1M	4.5M	8.6M	178K	169.1K
Property Plant And Equipment Net	945K	2.5M	3.1M	1.2M	216K	205.2K
Accounts Payable	2.9M	1.8M	2.5M	2.9M	2.6M	2.5M
Non Currrent Assets Other	83K	(1.1M)	1.5M	51K	1.6M	1.7M
Other Assets	2.4M	7.2M	1.2M	1.1M	1.3M	1.2M
Short Term Investments	982K	9.3M	2.7M	1.5M	1.7M	1.6M
Inventory	326K	353K	1.2M	718K	825.7K	562.5K
Other Current Assets	4.3M	1.2M	2.3M	1.4M	716K	1.3M
Property Plant And Equipment Gross	945K	2.7M	3.6M	1.2M	1.4M	1.9M
Accumulated Other Comprehensive Income	(1.9M)	8.3M	(915K)	(1.5M)	(1.4M)	(1.4M)
Capital Stock	192K	233K	228K	299K	343.9K	247.9K
Property Plant Equipment	945K	2.5M	2.6M	1.2M	1.4M	1.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Renalytix Stock Analysis

When running Renalytix's price analysis, check to measure Renalytix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix is operating at the current time. Most of Renalytix's value examination focuses on studying past and present price action to predict the probability of Renalytix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix's price. Additionally, you may evaluate how the addition of Renalytix to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Renalytix Total Current Liabilities vs Net Tangible Assets Analysis

Total Current Liabilities vs Net Tangible Assets

Total Current Liabilities vs Net Tangible Assets Correlation Analysis

Correlation Coefficient

Total Current Liabilities

Net Tangible Assets

Renalytix fundamental ratios Correlations

Renalytix Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Renalytix fundamental ratios Accounts

Also Currently Popular

Additional Tools for Renalytix Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Short Term Debt	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.99	Total Current Liabilities

Net Debt	- 0.98	Total Stockholder Equity
Total Current Assets	- 0.97	Net Debt
Cash And Short Term Investments	- 0.97	Net Debt
Cash	- 0.97	Net Debt
Net Debt	- 0.97	Net Tangible Assets
Net Debt	- 0.96	Total Assets